Join the 'Chronic Obstructive Pulmonary Disease' group to help and get support from people like you.

Chronic Obstructive Pulmonary Disease Blog

Related terms: Bronchitis, Chronic, Bronchitis with Airway Obstruction, Chronic Bronchitis, Chronic Obstructive Airway Disease, Chronic Obstructive Lung Disease, Emphysema, COPD

COPD Raises Cardiac Death Risk for Those With Irregular Heartbeat

Posted 2 days 19 hours ago by Drugs.com

WEDNESDAY, May 20, 2015 – Chronic obstructive pulmonary disease (COPD) increases the risk of all-cause and heart-related death in people with the common heart rhythm disorder known as atrial fibrillation, a new study finds. However, COPD doesn't increase the risk of stroke, the researchers said. COPD is a term used to describe the diseases emphysema and chronic bronchitis. COPD is the third leading cause of death in the United States, according to the U.S. Centers for Disease Control and Prevention. "Other studies have shown that COPD is an independent risk factor for cardiovascular disease, but what hadn't been studied was whether COPD was an independent risk factor for stroke, specifically among patients with atrial fibrillation," study author Dr. Michael Durheim, a pulmonary and critical care fellow at Duke University in Durham, N.C., said in an American Thoracic Society news ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Atrial Fibrillation, Arrhythmia, Chronic Obstructive Pulmonary Disease, Maintenance, Chronic Obstructive Pulmonary Disease, Acute

Rural Poor Bear Higher Burden of COPD, Study Finds

Posted 4 days ago by Drugs.com

TUESDAY, May 19, 2015 – Being poor and living in a rural area are two risk factors for chronic obstructive pulmonary disease (COPD), a new study finds. COPD is a progressive and incurable lung condition that involves a combination of emphysema and chronic bronchitis. It is often linked to smoking, and is the third leading cause of death in the world. In the new study, researchers led by author Dr. Sarath Raju of the Johns Hopkins School of Medicine in Baltimore reviewed data from almost 88,000 American adults older than 40. They found that 7.2 percent of them had COPD. However, the rate of COPD was closer to 12 percent among those who lived in poor and rural areas, Raju's team found. Why would people in rural areas be at higher risk? The reasons aren't clear, the team said. They said there's a need for research "to understand the potential contribution of occupational exposures, fuel ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Bronchitis, Chronic Obstructive Pulmonary Disease, Maintenance, Chronic Obstructive Pulmonary Disease, Acute

COPD Tied to Raised Risk for Sudden Cardiac Death

Posted 29 Apr 2015 by Drugs.com

WEDNESDAY, April 29, 2015 – Chronic obstructive pulmonary disease (COPD) is already the third leading cause of death in the world, and a new European study finds the respiratory illness might also raise a person's odds for sudden cardiac death. COPD is a progressive and incurable illness that involves a combination of emphysema and bronchitis, and is often tied to smoking. The researchers said that the disease has already been associated with an increased risk of heart disease and sudden cardiac death in certain high-risk patient populations. Now, the new study "shows that COPD is a risk indicator for sudden cardiac death in the general population, and that the risk increases with COPD severity," wrote a team led by Dr. Lies Lahousse, a postdoctoral researcher at Ghent University Hospital in Belgium. One expert in the United States said that even though the study can't prove that COPD ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Atrial Fibrillation, Chronic Obstructive Pulmonary Disease, Maintenance, Chronic Obstructive Pulmonary Disease, Acute, Heart Block, Cardiac Arrhythmia

Home Oxygen Raises Burn Risk for COPD Patients

Posted 2 Apr 2015 by Drugs.com

THURSDAY, April 2, 2015 – Use of home oxygen puts patients with chronic obstructive pulmonary disease (COPD) at risk for burns, a new study indicates. Oxygen therapy is a common treatment for people with the lung disease. But there is a burn risk for patients who smoke, because having a heat or flame source near oxygen gas can trigger a fire. Researchers looked at 685 Medicare patients with COPD who suffered burns between 2001 and 2010 and 2,055 who did not. Those who suffered burns were more likely to have been prescribed home oxygen therapy within 90 days prior to their burns. "The benefits of oxygen in COPD patients outweigh the modest risks of burn injury," said senior study author Dr. Alexander Duarte, a professor in the division of pulmonary critical care and sleep medicine at the University of Texas Medical Branch at Galveston. "However, health care professionals should educate ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease

COPD Takes Big Toll on Employment, Mobility in U.S.

Posted 26 Mar 2015 by Drugs.com

THURSDAY, March 26, 2015 – The respiratory illness known as COPD takes a toll on mobility and employment, with a new report finding that nearly one-quarter of Americans with the condition are unable to work. People with chronic obstructive pulmonary disorder – a combination of chronic bronchitis and emphysema often tied to smoking – face a disabling illness with no cure, according to the report from the U.S. Centers for Disease Control and Prevention. Looking at U.S. health data for 2013, a team led by CDC investigator Anne Wheaton found that just over 24 percent of adults with COPD say they cannot work, compared to about 5 percent of adults in the general population. About half of those with COPD said they also had some form of "activity limitation" linked to their condition, and more than 38 percent said they found it difficult to walk or climb stairs. Because smoking is a major ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease

Healthy Diet May Be Linked to Lower Risk of Lung Disease

Posted 4 Feb 2015 by Drugs.com

TUESDAY, Feb. 3, 2015 – A healthy diet low in red meat and rich in whole grains might reduce the risk of developing the crippling chronic lung disease known as COPD, new research suggests. Researchers tracked more than 120,000 men and women and found healthy eaters were one-third less likely to develop COPD compared to big consumers of red meat, refined grains, sugary drinks and alcohol. "The predominant risk factor for COPD in the developed world is cigarette smoking," said study lead author Raphaelle Varraso, a researcher with the unit of aging and chronic diseases at the National Institute of Health and Medical Research in Villejuif, France. "But up to one-third of COPD patients have never smoked, suggesting that other factors are involved," Varraso said. "This novel finding supports the importance of diet in COPD [development]." The study was published online Feb. 3 in the BMJ. The ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease

Nearly Half of Older Adults With Asthma, COPD Still Smoke: CDC

Posted 7 Jan 2015 by Drugs.com

WEDNESDAY, Jan. 7, 2015 – Close to half of U.S. adults over 40 who have trouble breathing due to asthma or COPD still continue to smoke, federal health officials reported Wednesday. The findings highlight the difficulty facing many smokers trying to quit – even when smoking exacerbates an already distressing illness, one expert said. However, "with assistance, quitting may still be challenging but it is possible," said Patricia Folan, director of the Center for Tobacco Control at North Shore-LIJ Health System in Great Neck, N.Y. The new U.S. Centers for Disease Control and Prevention (CDC) statistics come a day after the release of another agency report, which found that 15 percent of Americans between 40 and 79 years of age suffer from some form of lung obstruction – typically asthma or chronic obstructive pulmonary disease (COPD). COPD, a progressive illness often linked to ... Read more

Related support groups: Asthma, Chronic Obstructive Pulmonary Disease

About 1 in 7 Older Adults Has Some Form of Lung Disease: CDC

Posted 7 Jan 2015 by Drugs.com

TUESDAY, Jan. 6, 2015 – Nearly 15 percent, or about one out of seven, middle-aged and older U.S. adults suffer from lung disorders such as asthma or chronic obstructive pulmonary disease (COPD), health officials said Tuesday. While 10 percent of those people experience mild breathing problems, more than one-third of them report moderate or severe respiratory symptoms, the U.S. Centers for Disease Control and Prevention (CDC) reported. "There are a huge number of Americans that experience lung obstruction," said Dr. Norman Edelman, a senior medical advisor to the American Lung Association, who was not involved in the research. "It's a major problem; it's the third leading cause of death in the United States." People with asthma or COPD – which includes emphysema and chronic bronchitis – have reduced airflow and shortness of breath. For the report, CDC researchers analyzed national ... Read more

Related support groups: Asthma, Chronic Obstructive Pulmonary Disease, Respiratory Tract Disease

Some Lung Patients Buy Cigarettes Along With Meds at Pharmacies: Study

Posted 20 Oct 2014 by Drugs.com

MONDAY, Oct. 20, 2014 – While picking up a prescription for cholesterol-lowering medication, about one in 20 people with conditions such as asthma, chronic obstructive pulmonary disease (COPD) or high blood pressure will also purchase cigarettes, a new study finds. Six percent of people with asthma or COPD, and about 5 percent of people with high blood pressure or those picking up oral contraceptive bought cigarettes, the researchers found. "While smoking itself can cause many health problems, it can worsen certain conditions and have other effects on medications," said lead researcher Joshua Gagne, an assistant professor of medicine at Harvard Medical School in Boston. For example, smoking can worsen respiratory conditions and can increase blood pressure, the researchers wrote. Smoking can also increase the risk of heart attack and stroke in oral contraceptives users, Gagne said. In ... Read more

Related support groups: High Blood Pressure, Hypertension, Asthma, Smoking, Chronic Obstructive Pulmonary Disease

FDA Approves Spiriva Respimat (tiotropium) for the Maintenance Treatment of COPD

Posted 25 Sep 2014 by Drugs.com

Ridgefield, Conn., September 25, 2014 – Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved Spiriva Respimat (tiotropium bromide) inhalation spray for the long-term, once-daily maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema and to reduce exacerbations in COPD patients. Boehringer Ingelheim anticipates Spiriva Respimat to be available in January 2015. Spiriva Respimat provides a pre-measured amount of medicine in a slow-moving mist that helps patients inhale the medicine. Spiriva Respimat was developed to actively deliver medication in a way that does not depend of how fast air is breathed in from the inhaler. Spiriva Respimat has the same active ingredient as Spiriva HandiHaler (tiotropium bromide inhalation powder), which is ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Spiriva, Chronic Obstructive Pulmonary Disease, Maintenance, Spiriva HandiHaler, Tiotropium

Combo Therapy Best for COPD: Study

Posted 16 Sep 2014 by Drugs.com

TUESDAY, Sept. 16, 2014 – A combination drug therapy aimed at opening the airways and reducing inflammation appears to be the best treatment for older adults with chronic obstructive pulmonary disease (COPD), especially those with asthma, a new study finds. COPD patients who received a combination of long-acting beta agonists and inhaled corticosteroids were less likely to die or require hospitalization because of their breathing disorder, compared to people receiving only one of the two medications, Canadian researchers report. The study findings were published in the Sept. 17 issue of the Journal of the American Medical Association. The findings go against the official guidelines for treating COPD, but actually support what most chest physicians are doing in the clinic, said lead author Dr. Andrea Gershon, a scientist with the Sunnybrook Health Sciences Center and the Institute for ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease, Maintenance, Advair Diskus, Advair HFA, Chronic Obstructive Pulmonary Disease, Acute, Breo Ellipta, Fluticasone/Salmeterol, Fluticasone/vilanterol

FDA Approves Striverdi Respimat - New Treatment for People With COPD

Posted 1 Aug 2014 by Drugs.com

FRIDAY, Aug. 1, 2014 – Patients with the progressive, deadly respiratory ailment known as chronic obstructive pulmonary disease (COPD) have a new weapon to battle the disease, the U.S. Food and Drug Administration said Thursday. The agency approved a new treatment, an inhaled spray called Striverdi Respimat (olodaterol) for COPD, the third leading killer of Americans. COPD, which is often linked to smoking, involves multiple lung conditions such as chronic bronchitis and emphysema. Patients with COPD may experience a number of symptoms, such as wheezing, coughing and tightness in their chest. According to the FDA, Striverdi Respimat belongs to a class of medicines known as long-acting beta-adrenergic agonists (LABAs). The agency said the drug works by helping the airway muscles in the lungs stay relaxed, and it can be taken once daily over a prolonged period of time. "The availability ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease, Maintenance

Once-Daily Striverdi Respimat Inhaler Approved for COPD

Posted 31 Jul 2014 by Drugs.com

THURSDAY, July 31, 2014 – Striverdi Respimat (olodaterol) inhalation spray has been approved by the U.S. Food and Drug Administration to treat chronic obstructive pulmonary disease (COPD), the agency said Thursday in a news release. COPD, which includes chronic bronchitis and chronic emphysema, is a progressive disease that makes breathing difficult by obstructing airflow through the lungs. Most commonly caused by smoking, it's the third-leading cause of death in the United States, the FDA said. The once-daily inhaler relaxes lung airways, improving breathing. It was evaluated in a clinical study of more than 3,100 people diagnosed with COPD. The drug's label will carry a boxed warning that it increases the risk of asthma-related death. The FDA said Striverdi Respimat hasn't been evaluated among people with asthma and is not approved to treat asthma or sudden breathing problems such as ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease, Maintenance

FDA Approves Striverdi Respimat to Treat Chronic Obstructive Pulmonary Disease

Posted 31 Jul 2014 by Drugs.com

July 31, 2014 – Today, the U.S. Food and Drug Administration approved Striverdi Respimat (olodaterol) inhalation spray to treat patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema that are experiencing airflow obstruction. Striverdi Respimat can be used once daily over a long period of time. COPD is a serious lung disease that makes breathing difficult and worsens over time. Symptoms can include wheezing, cough, chest tightness, and shortness of breath. Cigarette smoking is the leading cause of COPD. According to the National Heart, Lung, and Blood Institute, COPD is the third leading cause of death in the United States. “The availability of this new long-term maintenance medication provides an additional treatment options for the millions of Americans who suffer with COPD,” said Curtis Rosebraugh, M.D., M.P.H., director of the Off ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease, Maintenance

Annual COPD Costs To Hit $49 Billion by 2020: CDC

Posted 30 Jul 2014 by Drugs.com

WEDNESDAY, July 30, 2014 – Medical costs for chronic obstructive pulmonary disease (COPD) in the United States are more than $32 billion each year, according to new research from the U.S. Centers for Disease Control and Prevention. The yearly financial toll of COPD (which includes emphysema and chronic bronchitis) is expected to reach an estimated $49 billion by 2020. "For the first time, our analyses provide state-specific costs for COPD, which provide state public health practitioners with estimates of the economic burden of COPD within their borders and illustrates the potential medical and absenteeism costs savings to states through implementing state level programs that are designed to prevent the onset of COPD," Dr. Earl Ford, of the CDC's division of population health, said in a news release from the journal CHEST. Medical costs associated with COPD were primarily paid for by ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease, Maintenance, Chronic Obstructive Pulmonary Disease, Acute

Page 1 2 3 4 5 6 7 8 Next

Ask a Question

Further Information

Related Condition Support Groups

Chronic Obstructive Pulmonary Disease, Maintenance, Chronic Obstructive Pulmonary Disease, Acute, Alpha-1 Proteinase Inhibitor Deficiency, Respiratory Tract Disease

Related Drug Support Groups

prednisone, Symbicort, montelukast, Daliresp, Bronchial, Breo Ellipta, Tudorza Pressair, guaifenesin / theophylline, Bronkometer, view more... isoetharine, Rayos, Uni Bronchial, Theocon, Theolate, Broncomar GG, Theophyll-GG, Bronkosol, Broncodur, Glyceryl T, Ed-Bron G, Equibron G, Theo G, Solu-Phyllin GG, Lufyllin-400, umeclidinium / vilanterol, umeclidinium, olodaterol, fluticasone / vilanterol, aclidinium, dyphylline, roflumilast, Dylix, Dilor, budesonide / formoterol, Dilor-400, Asbron G, Neothylline, Theomar GG, Lufyllin, Quibron, Slo-Phyllin GG